Heptazine‐based polymeric carbon nitrides (PCN) are promising photocatalysts for light‐driven redox transformations. However, their activity is hampered by low surface area resulting in low concentration of accessible active sites. Herein, we report a bottom‐up preparation of PCN nanoparticles with a narrow size distribution (ca. 10±3 nm), which are fully soluble in water showing no gelation or precipitation over several months. They allow photocatalysis to be carried out under quasi‐homogeneous conditions. The superior performance of water‐soluble PCN, compared to conventional solid PCN, is shown in photocatalytic H2O2 production via reduction of oxygen accompanied by highly selective photooxidation of 4‐methoxybenzyl alcohol and benzyl alcohol or lignocellulose‐derived feedstock (ethanol, glycerol, glucose). The dissolved photocatalyst can be easily recovered and re‐dissolved by simple modulation of the ionic strength of the medium, without any loss of activity and selectivity.

Two different structures of zeolites, faujasite (FAU) and Linde type A (LTA), were studied to investigate their suitability for drug delivery systems (DDS). The zeolites in the sodium form (NaY and NaA) were used as hosts for encapsulation of α-cyano-4hydroxycinnamic acid (CHC). CHC, an experimental anticancer drug, was encapsulated in both zeolites by diffusion in liquid phase. These new drug delivery systems, CHC@zeolite, were characterized by spectroscopic techniques (FTIR, 1 H NMR, 13 C and 27 Al solidstate MAS NMR, and UV−vis), chemical analysis, powder X-ray diffraction (XRD) and scanning electron microscopy (SEM). The effect of the zeolites and CHC@zeolite drug deliveries on HCT-15 human colon carcinoma cell line viability was evaluated. Both zeolites alone revealed no toxicity to HCT-15 cancer cells. Importantly, CHC@zeolite exhibit an inhibition of cell viability up to 585-fold, when compared to the non-encapsulated drug. These results indicate the potential of the zeolites for drug loading and delivery into cancer cells to induce cell death. 50 previously reported the preparation of a DDS based in zeolite Y 51 with an anticancer drug and demonstrated its efficacy against 52 colorectal carcinoma (CRC) cells in vitro. 22 CRC is the most 53 common type of tumor in Western countries, being men 54 slightly more often affected. 23 Treatment of CRC includes 55 surgery, radiotherapy, and/or chemotherapy. However, the 56 treatment design depends largely on the cancer stage. Despite 57 the progress made with the introduction of new cytotoxic 58 agents 24−28 and medical practices, survival rates of patients with 59 CRC changed little over the last 20 years, 29 justifying the need 60 for more effective therapies and new drugs. 61 α-Cyano-4-hydroxycinnamic acid (CHC) is a compound 62 derived from cinnamic acid and is a competitive inhibitor of 63 monocarboxylate transporter 1 (MCT1), 30 a protein recently 64 shown to be upregulated in colorectal and other cancers and 65 thus a potential target for cancer therapy. 31−33 Published data 66 demonstrated the cytotoxic and cytostatic effectiveness of 67 CHC, 34,35 both in vitro and in vivo. 36,37 CHC used here in a 68 model of colon carcinoma was chosen as a guest in two 69 different structures of zeolites for drug delivery. Due to their 70 structural properties, zeolites have attracted much research

The studies of potentiation of 5-fluorouracil (5-FU), a traditional drug used in the treatment of several cancers, including colorectal (CRC), were carried out with zeolites Faujasite in the sodium form, with different particle sizes (NaY, 700nm and nanoNaY, 150nm) and Linde type L in the potassium form (LTL) with a particle size of 80nm. 5-FU was loaded into zeolites by liquid-phase adsorption. Characterization by spectroscopic techniques (FTIR, (1)H NMR and (13)C and (27)Al solid-state MAS NMR), chemical analysis, thermal analysis (TGA), nitrogen adsorption isotherms and scanning electron microscopy (SEM), demonstrated the successful loading of 5-FU into the zeolite hosts. In vitro drug release studies (PBS buffer pH 7.4, 37°C) revealed the release of 80-90% of 5-FU in the first 10min. To ascertain the drug release kinetics, the release profiles were fitted to zero-order, first-order, Higuchi, Hixson-Crowell, Korsmeyer-Peppas and Weibull kinetic models. The in vitro dissolution from the drug delivery systems (DDS) was explained by the Weibull model. The DDS efficacy was evaluated using two human colorectal carcinoma cell lines, HCT-15 and RKO. Unloaded zeolites presented no toxicity to both cancer cells, while all DDS allowed an important potentiation of the 5-FU effect on the cell viability. Immunofluorescence studies provided evidence for zeolite-cell internalization.

Chemisorbent materials, based on porous aminosilicas, are amongst the most promising adsorbents for direct air capture applications, one of the key technologies to mitigate carbon emissions. Herein, a critical survey of all reported chemisorbed CO2 species, which may form in aminosilica surfaces, is performed by revisiting and providing new experimental proofs of assignment of the distinct CO2 species reported thus far in the literature, highlighting controversial assignments regarding the existence of chemisorbed CO2 species still under debate. Models of carbamic acid, alkylammonium carbamate with different conformations and hydrogen bonding arrangements were ascertained using density functional theory (DFT) methods, mainly through the comparison of the experimental 13 C and 15 N NMR chemical shifts with those obtained computationally. CO2 models with variable number of amines and silanol groups were also evaluated to explain the effect of amine aggregation in CO2 speciation under confinement. In addition, other less commonly studied chemisorbed CO2 species (e.g., alkylammonium bicarbonate, ditethered carbamic acid and silylpropylcarbamate), largely due to the difficulty in obtaining spectroscopic identification for those, have also been investigated in great detail. The existence of either neutral or charged (alkylammonium siloxides) amine groups, prior to CO2 adsorption, is also addressed. This work extends the molecular-level understanding of chemisorbed CO2 species in amine-oxide hybrid surfaces showing the benefit of integrating spectroscopy and theoretical approaches.

The wealth of site-selective structural information on CO speciation, obtained by spectroscopic techniques, is often hampered by the lack of easy-to-control synthetic routes. Herein, an alternative experimental protocol that relies on the high sensitivity of C chemical shift anisotropy (CSA) tensors to proton transfer, is presented to unambiguously distinguish between ionic/charged and neutral CO species, formed upon adsorption of CO in amine-modified porous materials. Control of the surface amine spacing was achieved through the use of amine protecting groups during functionalisation prior to CO adsorption. This approach enabled the formation of either "isolated" or "paired" carbamate/carbamic acid species, providing a first experimental NMR proof towards the identification of both aggregation states. Computer modelling of surface CO -amine adducts assisted the solid-state NMR assignments and validated various hydrogen-bond arrangements occurring upon formation of isolated/aggregated carbamic acid and alkylammonium carbamate ion species. This work extends the understanding of chemisorbed CO structures formed at pore surfaces and reveals structural insight about the protonation source responsible for the proton-transfer mechanism in such aggregates.